Ardent Health, Inc. (NASDAQ: ARDT) is catching the attention of investors, boasting a robust 48.52% potential upside, as it currently trades at $13.68. Situated in the ever-dynamic healthcare sector, Ardent..
For investors eyeing the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a unique opportunity within the medical devices industry. Based in San Jose, California, PROCEPT BioRobotics has carved out..
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to tackling chronic diseases. Based in South San Francisco, the..
Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, operates within the health information services industry, providing innovative medication management solutions to healthcare systems and pharmacies in the..
Investors with a keen eye on the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing opportunity, given its significant potential upside of 121.81%. This late-stage clinical biopharmaceutical..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is a prominent player in the rapidly evolving biotechnology sector, leveraging cutting-edge technological advancements to redefine drug discovery. Headquartered in Salt Lake City, Utah, this..
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is turning heads in the healthcare sector with its promising pipeline of treatments for diseases with unmet needs, particularly in the cardiovascular domain. With a..
Travere Therapeutics, Inc. (NASDAQ: TVTX) has captured investor attention with its impressive potential upside of 133.30%, driven by its focused endeavors in addressing rare kidney and metabolic diseases. As a..
Investors looking for opportunities in the biotechnology sector may want to keep a close watch on Vera Therapeutics, Inc. (VERA). As a clinical-stage biotech firm, Vera Therapeutics focuses on developing..
Privia Health Group, Inc. (PRVA), a compelling player in the healthcare sector, operates as a national physician-enablement company in the United States. With a market capitalization of $2.83 billion, Privia..
Celldex Therapeutics, Inc. (NASDAQ: CLDX), a cutting-edge biopharmaceutical company headquartered in Hampton, New Jersey, is making waves in the biotechnology sector. Specializing in the development of therapeutic antibodies targeting severe..
BioCryst Pharmaceuticals, Inc. (BCRX), a prominent player in the healthcare sector, focuses on developing innovative treatments for rare diseases. With a current market capitalization of $2.32 billion, this Durham, North..
Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, has caught the attention of investors with its ambitious vaccine development pipeline and a striking potential upside of..
Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector with its innovative approach to treating serious hematologic diseases. As a clinical-stage biopharmaceutical company, Disc Medicine is dedicated..
Janux Therapeutics, Inc. (NASDAQ: JANX), a pioneering player in the biotechnology sector, has captured the attention of investors with its promising pipeline of cancer immunotherapies. With a market capitalization of..
Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the Healthcare sector, particularly within the Diagnostics & Research industry, continues to captivate investors with its innovative synthetic DNA-based products. Headquartered..
SS Innovations International, Inc. (SSII) is a burgeoning player in the healthcare sector, particularly within the medical devices industry. Headquartered in Gurugram, India, the company is carving out a niche..
For investors with an eye for opportunity in the healthcare sector, PACS Group, Inc. (PACS) presents an intriguing proposition. Operating within the medical care facilities industry, PACS Group is headquartered..
Clover Health Investments, Corp (NASDAQ: CLOV) is capturing investor attention with a substantial potential upside of 57.30%, according to recent analyst ratings. Positioned within the healthcare sector, specifically focusing on..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a biotech entity focused on pioneering therapeutics in the realm of cellular metabolism, is capturing investor attention with its promising portfolio and substantial upside potential...
